Pachymeter device market seen reaching $25.28 billion by 2030

The pachymeter device market is projected to grow from $21.21 billion in 2026 to $25.28 billion by 2030, supported by rising eye-disease diagnoses, broader outpatient eye care and new imaging technologies. North America led the market in 2025 as demand for non-invasive corneal measurement tools continues to build.

Why it matters: - Pachymeters help clinicians measure corneal thickness, a key input for diagnosing and managing glaucoma, corneal edema and refractive surgery planning. - Rising eye-disease prevalence is increasing demand for faster, more precise ophthalmic diagnostics. - The market’s projected 4.5% CAGR through 2030 points to steady long-term demand in eye care.

What happened: - The Business Research Company released its Pachymeter Device Market Report 2026 covering market size, trends and global forecasts for 2026-2035. - The report says the global pachymeter device market will grow from $20.19 billion in 2025 to $21.21 billion in 2026. - The market is forecast to reach $25.28 billion by 2030. - The report projects a 4.5% CAGR over the forecast period. - North America held the largest regional share in 2025.

The details: - Historical growth has been supported by higher rates of glaucoma and corneal disorders. - Growth also reflects more ophthalmology clinics, more refractive surgeries and wider use of ultrasound-based eye diagnostics. - Advances in optical imaging have also helped expand demand. - The forecast period is supported by stronger demand for early glaucoma detection. - Wider use of advanced anterior segment imaging is another growth driver. - Expansion of outpatient eye care services should support adoption. - Increased investment in ophthalmic diagnostics is expected to add momentum. - A stronger focus on non-invasive eye exams is shaping purchasing decisions. - Emerging trends include non-contact optical pachymeters. - OCT-based corneal measurement systems are gaining adoption. - Demand is rising for portable ophthalmic devices. - Integrated diagnostic platforms are expanding. - Manufacturers are improving measurement speed and accuracy. - A pachymeter measures corneal thickness, the transparent front layer of the eye. - The device is used in clinical decision-making and monitoring of ocular disease. - The report cites UK Office for Health Improvement and Disparities data showing about 2 million people in the UK had some form of sight loss in May 2024. - That figure is expected to rise to 2.7 million by 2030. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market is moving toward less invasive and more portable diagnostic tools, which could broaden use beyond specialist settings. - North American leadership suggests mature demand today, while faster growth elsewhere may come from expanding eye-care infrastructure and awareness. - The mix of imaging upgrades and outpatient growth points to diagnostics becoming more integrated into routine eye care.

What's next: - The report expects continued growth through 2030 as early detection and non-invasive measurement become more important. - Wider adoption of advanced imaging and integrated platforms could shape product development and purchasing patterns. - The company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards and updated graphics and tables. - More information is available in the free sample report and the full market report.

The bottom line: - Pachymeter devices sit in a growing ophthalmic diagnostics market fueled by more eye disease, more imaging and a shift toward non-invasive care.